Post by Suanfarma

In a recent interview with Revista Sector Ejecutivo, our CEO, Pere Mañé, reflects on Suanfarma’s evolution and the company’s priorities for the years ahead. Suanfarma is moving into a new phase guided by its 2026–2030 Strategic Plan. Our focus is on strengthening industrial competitiveness, enhancing our technological capabilities, advancing digital transformation, developing our proprietary API portfolio and CDMO services, and reinforcing our international presence. This direction is supported by our European industrial platform, international network and shared commitment to operational excellence, collaboration, accountability and customer focus. As Pere highlights, succeeding in the pharmaceutical industry requires combining long-term strategic vision with disciplined execution, while ensuring quality, regulatory compliance and supply reliability at every step. Thank you to Revista Sector Ejecutivo for the opportunity to share Suanfarma’s perspective and priorities for the future. 🔗 Read the interview: https://lnkd.in/e89MTjgB #Suanfarma #Leadership #PharmaceuticalIndustry #APIs #CDMO #LifeSciences #Strategy